Cart is empty A new research perspective titled “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies” has been published in Oncotarget.
A new research perspective titled “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies” has been published in Oncotarget.
Leave A Comment